BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 304823)

  • 1. T cells, precocious aging, and familial neoplasia.
    Fudenberg HH; Schuman SH; Goust JM; Jorgenson R
    Gerontology; 1978; 24(4):266-75. PubMed ID: 304823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophoretic mobility of T and B lymphocytes in bone tumor patients].
    Xie GL
    Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):39-41. PubMed ID: 3015533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteogenic sarcoma in children: clinico-immunological correlations].
    Panteleeva ES; Neprina GS; Vatin OE; Bizer VA; Kurasova VG
    Vopr Onkol; 1990; 36(3):304-8. PubMed ID: 2139527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinico-immunological studies of 32 cases of bone tumors].
    Franchi F; Russo V; Luzi G; Santori FS; De Chiara N; Aiuti F
    Minerva Med; 1980 Jun; 71(25):1815-22. PubMed ID: 6968049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Decreased count of small lymphocytes in the blood of patients with malignant bone tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA; Efimtseva NN; Baranovskaia VT
    Vopr Onkol; 1987; 33(9):15-21. PubMed ID: 3499033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of selected parameters of cellular immunity in children with osteosarcoma at diagnosis].
    Markiewicz K; Zeman K; Kozar A; Gołębiowska-Wawrzyniak M; Woźniak W
    Med Wieku Rozwoj; 2012; 16(3):212-21. PubMed ID: 23378399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immunomodulating action of combined therapy together with local UHF hyperthermia in osteogenic sarcoma in children].
    Neprina GS; Panteleeva ES; Vatin OE; Bizer VA; Boĭko IN
    Med Radiol (Mosk); 1989 Dec; 34(12):39-44. PubMed ID: 2601592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymus-dependent and nonthymus-dependent lymphocytes in patients with sarcomas.
    Pritchard DJ; Miller GC; Ritts RE; Ivins JC
    Cancer; 1977 Aug; 40(2):803-7. PubMed ID: 302142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on various parameters of the T-dependent lymphocyte system in the course of osteosarcoma].
    Marinoni I; Torelli L
    Boll Ist Sieroter Milan; 1976; 55(6):548-52. PubMed ID: 1088075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lymphocyte subpopulations in malignant bone tumors and their relation to the immune response to the tumor].
    Kosmiadi GA; Grigor'eva MP; Govallo VI
    Vopr Onkol; 1981; 27(2):43-7. PubMed ID: 6971012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer factor therapy in osteogenic sarcoma.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO
    Trans Assoc Am Physicians; 1974; 87():153-8. PubMed ID: 4549141
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the T- and B-lymphocyte ratio in bone sarcoma patients before and after carminomycin treatment].
    Vatin AE; Bizer VA
    Antibiotiki; 1980 Nov; 25(11):864-7. PubMed ID: 6969572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocompetence of lymphocytes from osteosarcoma patients.
    McMaster JH; Weinert CR; Dickens DR
    Lancet; 1973 Apr; 1(7806):781-2. PubMed ID: 4120769
    [No Abstract]   [Full Text] [Related]  

  • 14. Longitudinal studies of cellular immunity of patients with osteogenic sarcoma during chemoimmunotherapy.
    Sears HF; Simon R; Rosenberg SA
    Cancer Treat Rep; 1980; 64(4-5):589-97. PubMed ID: 6933004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
    Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
    Pathol Res Pract; 1998; 194(10):679-84. PubMed ID: 9820863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteosarcoma in a patient with Hutchinson-Gilford progeria.
    King CR; Lemmer J; Campbell JR; Atkins AR
    J Med Genet; 1978 Dec; 15(6):481-4. PubMed ID: 284134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active and suppressor T cells: diminution in a patient with dyskeratosis congenita and in first-degree relatives.
    Fudenberg HH; Goust JM; Vesole DH; Salinas CF
    Gerontology; 1979; 25(4):231-7. PubMed ID: 313356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indices of cellular and humoral immunity following surgery intervention for malignant bone tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA; Zatsepin ST; Makhson NE
    Vopr Onkol; 1976; 22(1):7-13. PubMed ID: 1083589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the methods of rosette formation in oncological patients].
    Vatin AE
    Lab Delo; 1980; (4):236-7. PubMed ID: 6155553
    [No Abstract]   [Full Text] [Related]  

  • 20. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO; Spitler LE
    J Clin Invest; 1975 Mar; 55(3):487-99. PubMed ID: 1078826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.